Royal Bank Of Canada Anebulo Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.9 - $3.12 $24 - $40	13 Added 34.21%	51 $0
Q1 2024 Nov 05, 2024	SELL	$2.34 - $3.0 $30 - $39	-13 Reduced 25.49%	38 $0
Q1 2024 May 15, 2024	SELL	$2.34 - $3.0 $77 - $99	-33 Reduced 46.48%	38 $0
Q4 2023 Feb 14, 2024	BUY	$1.71 - $3.17 $39 - $72	23 Added 47.92%	71 $0
Q2 2023 Aug 14, 2023	BUY	$2.06 - $2.98 $98 - $143	48 New	48 $0

7.34M

Ticker ANEB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,633,200
Market Cap $33.3M
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.